Showing results (121-130 of 30,101) with videos related to
Sort By:
Pageof 3,011
Frontiers in Pharmacology|March 29, 2020
Neuroprotective Effect of Danhong Injection on Cerebral Ischemia-Reperfusion Injury in Rats by Activation of the PI3K-Akt PathwayChen Feng, Haofang Wan, Yangyang Zhang, et al.Frontiers in Pharmacology|March 29, 2020
Astaxanthin Ameliorated Parvalbumin-Positive Neuron Deficits and Alzheimer's Disease-Related Pathological Progression in the Hippocampus of App MiceNobuko Hongo, Yusaku Takamura, Hiroshi Nishimaru, et al.Frontiers in Pharmacology|March 29, 2020
Herbal Therapy for the Treatment of Acetaminophen-Associated Liver Injury: Recent Advances and Future PerspectivesLing Chang, Dongwei Xu, Jianjun Zhu, et al.Frontiers in Pharmacology|July 16, 2021
Analysis of Suspension of Clinical Trials for Drug Registration in ChinaXian Su, Xiaocong Pang, Xin Zeng, et al.Frontiers in Pharmacology|July 16, 2021
Combination Treatment With Inhibitors of ERK and Autophagy Enhances Antitumor Activity of Betulinic Acid in Non-small-Cell Lung Cancer In Vivo and In VitroChao-Yue Sun, Di Cao, Qian-Nan Ren, et al.Frontiers in Pharmacology|July 16, 2021
Microscopic Mass Spectrometry Imaging Reveals the Distribution of Phytochemicals in the Dried Root of Isatis tinctoriaLi-Xing Nie, Jing Dong, Lie-Yan Huang, et al.Frontiers in Pharmacology|July 16, 2021
Inhaled Corticosteroids and the Pneumonia Risk in Patients With Chronic Obstructive Pulmonary Disease: A Meta-analysis of Randomized Controlled TrialsHong Chen, Jian Sun, Qiang Huang, et al.Frontiers in Pharmacology|July 16, 2021
The Prostacyclin Analogue, Treprostinil, Used in the Treatment of Pulmonary Arterial Hypertension, is a Potent Antagonist of TREK-1 and TREK-2 Potassium ChannelsKevin P Cunningham, Lucie H Clapp, Alistair Mathie, et al.Frontiers in Pharmacology|July 16, 2021
Impact of Cost-Related Medication Nonadherence on Economic Burdens, Productivity Loss, and Functional Abilities: Management of Cancer Survivors in MedicareZ Kevin Lu, Xiaomo Xiong, Jacob Brown, et al.Frontiers in Pharmacology|July 15, 2021
Nicotinamide Riboside Vitamin B3 Mitigated C26 Adenocarcinoma-Induced Cancer CachexiaJong Min Park, Young Min Han, Ho Jae Lee, et al.Pageof 3,011